vs
Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and STEM, INC. (STEM). Click either name above to swap in a different company.
Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $47.1M, roughly 1.1× STEM, INC.). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs -33.9%, a 454.1% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs -15.6%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 36.1%).
Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
ARR vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.4M | $47.1M |
| Net Profit | $211.7M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | — | -17.7% |
| Net Margin | 420.2% | -33.9% |
| Revenue YoY | 297.9% | -15.6% |
| Net Profit YoY | 555.9% | 68.8% |
| EPS (diluted) | $2.43 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.4M | $47.1M | ||
| Q3 25 | $38.5M | $38.2M | ||
| Q2 25 | $33.1M | $38.4M | ||
| Q1 25 | $36.3M | $32.5M | ||
| Q4 24 | $12.7M | $55.8M | ||
| Q3 24 | — | $29.3M | ||
| Q2 24 | $7.0M | $34.0M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | $211.7M | $-16.0M | ||
| Q3 25 | $159.3M | $-23.8M | ||
| Q2 25 | $-75.6M | $202.5M | ||
| Q1 25 | $27.3M | $-25.0M | ||
| Q4 24 | $-46.4M | $-51.1M | ||
| Q3 24 | — | $-148.3M | ||
| Q2 24 | $-48.4M | $-582.3M | ||
| Q1 24 | — | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | 420.2% | -33.9% | ||
| Q3 25 | 413.5% | -62.2% | ||
| Q2 25 | -228.4% | 527.8% | ||
| Q1 25 | 75.2% | -76.9% | ||
| Q4 24 | -366.8% | -91.6% | ||
| Q3 24 | — | -506.3% | ||
| Q2 24 | -693.8% | -1712.6% | ||
| Q1 24 | — | -283.9% |
| Q4 25 | $2.43 | $-4.40 | ||
| Q3 25 | $1.49 | $-2.84 | ||
| Q2 25 | $-0.94 | $-1.79 | ||
| Q1 25 | $0.32 | $-0.15 | ||
| Q4 24 | $-0.91 | $-15.29 | ||
| Q3 24 | — | $-18.24 | ||
| Q2 24 | $-1.05 | $-71.81 | ||
| Q1 24 | — | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.3M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.3B | $-249.4M |
| Total Assets | $21.0B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.3M | $48.9M | ||
| Q3 25 | $44.2M | $43.1M | ||
| Q2 25 | $141.2M | $40.8M | ||
| Q1 25 | $49.1M | $58.6M | ||
| Q4 24 | $68.0M | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | $126.6M | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | $2.3B | $-249.4M | ||
| Q3 25 | $2.1B | $-235.7M | ||
| Q2 25 | $1.7B | $-214.1M | ||
| Q1 25 | $1.7B | $-417.5M | ||
| Q4 24 | $1.4B | $-398.4M | ||
| Q3 24 | — | $-344.1M | ||
| Q2 24 | $1.2B | $-203.2M | ||
| Q1 24 | — | $371.6M |
| Q4 25 | $21.0B | $308.9M | ||
| Q3 25 | $19.4B | $362.6M | ||
| Q2 25 | $16.2B | $379.2M | ||
| Q1 25 | $15.5B | $405.1M | ||
| Q4 24 | $13.5B | $437.4M | ||
| Q3 24 | — | $537.8M | ||
| Q2 24 | $10.1B | $691.5M | ||
| Q1 24 | — | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $124.2M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.2M | $8.2M | ||
| Q3 25 | $-37.8M | $11.4M | ||
| Q2 25 | $25.0M | $-21.3M | ||
| Q1 25 | $101.5M | $8.5M | ||
| Q4 24 | $261.5M | $-14.7M | ||
| Q3 24 | — | $-9.4M | ||
| Q2 24 | $27.1M | $-11.9M | ||
| Q1 24 | — | $-621.0K |
| Q4 25 | 0.59× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | 3.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
